期刊文献+

清肺平喘颗粒联合布地奈德治疗支气管哮喘疗效观察 被引量:4

Curative Efficacy of Qingfei Pingchuan Grain in Combination With Budesonide in the Treatment of Bronchial Asthma
下载PDF
导出
摘要 目的探讨清肺平喘颗粒联合布地奈德治疗支气管哮喘疗效及对患者肺功能改善的作用。方法 160例符合入选标准的支气管哮喘患者按治疗方案分为对照组(n=80)和观察组(n=80)。对照组给予布地奈德治疗,观察组联合应用清肺平喘颗粒治疗。比较两组患者临床疗效。结果观察组的治疗总有效率为92.5%,明显高于对照组81.2%的总有效率(P<0.05)。结论清肺平喘颗粒联合布地奈德对治疗支气管哮喘疗效可靠,值得临床上进一步研究。 Objective To investigate the clinical effect of qingfei pingchuan grain in combination with budesonide in treating bronchial asthma. Methods 160 cases of patients with bronchial asthma meeting the internal critera were selected and equally divided into two groups according to the therapeutic schemes. Besides conventional treatments, the control group was treated with budesonide, while the observation group was treated with qingfei pingchuan grain and budesonide. Then, the curative efficacy was compared. Results The observation group had a therapeutic efifciency ratio of 92.5%, which was signiifcantly higher than that of 81.2%in the control group (P〈0.05). Conclusion The curative effect of combined treatment of qingfei pingchuan grain with budesonide for bronchial asthma was reliable, which could increase the curative efifcacy and was worthy of being further studied.
作者 林明丰
出处 《中国继续医学教育》 2015年第2期178-179,共2页 China Continuing Medical Education
关键词 清肺平喘颗粒 布地奈德 支气管哮喘 Qingfei pingchuan grain Budesonide Bronchial asthma
  • 相关文献

参考文献7

二级参考文献25

  • 1何丽仪,张莲,苏健,罗昌寿,余声华,汪成恩.沙美特罗/丙酸氟替卡松治疗儿童中重度哮喘[J].广东医学,2004,25(8):979-980. 被引量:4
  • 2钟南山,郑劲平,蔡柏蔷,谢灿茂,孙铁英,王丹琪,林燕萍,陈宝元,陶家驹,康健,李强,许以平,周新,郭雪君,陈小东,殷凯生,张德平,周建英,沈华浩,邱晨,冯玉麟,肖邦榕.沙美特罗/丙酸氟替卡松干粉与布地奈德干粉吸入治疗成人支气管哮喘的临床疗效和安全性对照研究[J].中华结核和呼吸杂志,2005,28(4):233-237. 被引量:78
  • 3杨悦.沙美特罗/丙酸氟替卡松干粉剂和丙酸氟替卡松气雾剂治疗支气管哮喘的疗效比较[J].中国新药杂志,2006,15(9):721-723. 被引量:7
  • 4孔灵菲.最新全球哮喘防治指南解读[J].中国实用内科杂志,2007,27(4):255-257. 被引量:66
  • 5Scicchitano R,Aalbers R,Ukena D,et al.Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide immoderate to svere asthma[J].Current Medical Research and Opinion,2004,20(9):1403.
  • 6Partridge MR,Schuexmann W,Beckman O,et al.Effect on lung function and morning activities of budesorides/formoteral versus salmeteral/fluticasone in patients with COPD[J].Ther Adv Respir Dis,2009,3(4):1.
  • 7Palmqvist M,Arvidsson P,Beckman O,et al.Onset of bronchodilattion of budesonide/formoterol vs.salmeterol/fluticasone in single inhalers[J].Pulmonary Pharmacological Therapy,2001,14:29.
  • 8Sears MK,Radneo F.Safety of budeson′de/formoteral maintenance and relieves therapy in asthma trials[J].Respir Med,2009,103(12):196.
  • 9Bousquet J, Boulet LP, Peters MJ. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone[J]. Respir Med,2007 ; 101 (12) :243746.
  • 10Jenkins CR, Jones PW, Calverley P. Efficacy of salmeterol/fluticasone pro- pionate by GOLD stage of chronic obstructive pulmonary disease : analysis from the randomised, placebo-controlled TORCH study [ J ]. Respir Res, 2009 ;10(12) :594S3.

共引文献3692

同被引文献22

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部